BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34916087)

  • 1. Molecular mechanisms of thyroid cancer: A competing endogenous RNA (ceRNA) point of view.
    Liu Y; Khan S; Li L; Ten Hagen TLM; Falahati M
    Biomed Pharmacother; 2022 Feb; 146():112251. PubMed ID: 34916087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging role of competing endogenous RNA and associated noncoding RNAs in thyroid cancer.
    Bai Q; Pan Z; Nabi G; Rashid F; Liu Y; Khan S
    Am J Cancer Res; 2022; 12(3):961-973. PubMed ID: 35411240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of ncRNAs as ceRNAs in Gastric Cancer.
    Ye J; Li J; Zhao P
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emerging roles of non-coding competing endogenous RNA in hepatocellular carcinoma.
    Xu G; Xu WY; Xiao Y; Jin B; Du SD; Mao YL; Zhang ZT
    Cancer Cell Int; 2020; 20():496. PubMed ID: 33061848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competing endogenous RNA (ceRNA) cross talk and language in ceRNA regulatory networks: A new look at hallmarks of breast cancer.
    Abdollahzadeh R; Daraei A; Mansoori Y; Sepahvand M; Amoli MM; Tavakkoly-Bazzaz J
    J Cell Physiol; 2019 Jul; 234(7):10080-10100. PubMed ID: 30537129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic Associations between lncRNA/circRNA and miRNA in Hepatocellular Carcinoma.
    Han TS; Hur K; Cho HS; Ban HS
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32937886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analyzing the Interactions of mRNAs and ncRNAs to Predict Competing Endogenous RNA Networks in Osteosarcoma Chemo-Resistance.
    Zhu KP; Zhang CL; Ma XL; Hu JP; Cai T; Zhang L
    Mol Ther; 2019 Mar; 27(3):518-530. PubMed ID: 30692017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noncoding RNA:RNA Regulatory Networks in Cancer.
    Chan JJ; Tay Y
    Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29702599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncoding RNAs in gastric cancer: Research progress and prospects.
    Zhang M; Du X
    World J Gastroenterol; 2016 Aug; 22(29):6610-8. PubMed ID: 27547004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of dysregulated competing endogenous RNA networks in glioblastoma: A way toward improved therapeutic opportunities.
    Rahnama S; Bakhshinejad B; Farzam F; Bitaraf A; Ghazimoradi MH; Babashah S
    Life Sci; 2021 Jul; 277():119488. PubMed ID: 33862117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of RNA Expression Profiles in Thyroid Cancer to Construct a Competing Endogenous RNA (ceRNA) Network of mRNAs, Long Noncoding RNAs (lncRNAs), and microRNAs (miRNAs).
    Xu Y; Chen J; Yang Z; Xu L
    Med Sci Monit; 2019 Feb; 25():1140-1154. PubMed ID: 30745559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Noncoding RNA and Circular RNA: Two Rising Stars in Regulating Epithelial-Mesenchymal Transition of Pancreatic Cancer.
    Yang X; Qin C; Zhao B; Li T; Wang Y; Li Z; Li T; Wang W
    Front Oncol; 2022; 12():910678. PubMed ID: 35719940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Noncoding Competing Endogenous RNA Networks in Pancreatic Cancer.
    Xiong G; Pan S; Jin J; Wang X; He R; Peng F; Li X; Wang M; Zheng J; Zhu F; Qin R
    Front Oncol; 2021; 11():765216. PubMed ID: 34760707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms.
    Braga EA; Fridman MV; Moscovtsev AA; Filippova EA; Dmitriev AA; Kushlinskii NE
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarker potential of competing endogenous RNA networks in Polycystic Ovary Syndrome (PCOS).
    Heidarzadehpilehrood R; Pirhoushiaran M
    Noncoding RNA Res; 2024 Jun; 9(2):624-640. PubMed ID: 38571815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ceRNA Networks: The Backbone Role in Neoadjuvant Chemoradiotherapy Resistance/Sensitivity of Locally Advanced Rectal Cancer.
    He L; Chang H; Qi Y; Zhang B; Shao Q
    Technol Cancer Res Treat; 2021; 20():15330338211062313. PubMed ID: 34908512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and analysis of long non-coding RNA-associated competing endogenous RNA network for osteosarcoma metastasis.
    Fu Y; Liu Q; Bao Q; Wen J; Liu Z; Hu Y; He G; Peng C; Xu Y; Zhang W
    Hereditas; 2021 Feb; 158(1):9. PubMed ID: 33593435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of the SNHG7/microRNA‑9‑5p/DPP4 ceRNA network in the growth and
    Chen W; Yu J; Xie R; Zhou T; Xiong C; Zhang S; Zhong M
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?
    Mirzaei S; Zarrabi A; Hashemi F; Zabolian A; Saleki H; Ranjbar A; Seyed Saleh SH; Bagherian M; Sharifzadeh SO; Hushmandi K; Liskova A; Kubatka P; Makvandi P; Tergaonkar V; Kumar AP; Ashrafizadeh M; Sethi G
    Cancer Lett; 2021 Jul; 509():63-80. PubMed ID: 33838282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA H19 acts as a miR-340-3p sponge to promote epithelial-mesenchymal transition by regulating YWHAZ expression in paclitaxel-resistant breast cancer cells.
    Yan L; Yang S; Yue CX; Wei XY; Peng W; Dong ZY; Xu HN; Chen SL; Wang WR; Chen CJ; Yang QL
    Environ Toxicol; 2020 Sep; 35(9):1015-1028. PubMed ID: 32420678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.